> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# NDA Withdrawal Notice Corrected
- URL: https://www.fdaweb.com/nda-withdrawal-notice-corrected/
- Published: 2020-11-18T12:00:00.000Z
- Updated: 2026-09-14T16:36:54.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148115

*Federal Register* notice: FDA is correcting a notice that appeared in the 1/8 *Federal* Register announcing the approval withdrawals for 19 NDAs from multiple applicants. That notice indicated that FDA was withdrawing R2 Pharma’s NDA 202342, esomeprazole strontium delayed-release capsules. Because of clerical errors in the agency’s notification process, FDA has determined that the NDA remains approved and effect. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-11-18/pdf/2020-25413.pdf?ref=fdaweb.com).